Xatral Sr

Xatral SR is an extended-release oral medication containing alfuzosin hydrochloride, commonly prescribed to help manage symptoms of an enlarged prostate. It belongs to the alpha-blocker class, supporting urinary flow and reducing discomfort. This product is manufactured in the EU and intended for oral use only.

Xatral SR is primarily used to treat symptoms associated with benign prostatic hyperplasia (BPH), such as difficulty urinating, frequent urination, and the feeling of incomplete bladder emptying. It works by relaxing the muscles in the prostate and bladder neck, making it easier to pass urine. This medication is not intended for use in women or children.

Users of Xatral SR often report improved urinary flow and reduced urgency shortly after starting the medication. Some may experience a decrease in nighttime urination and overall bladder discomfort. Individual responses may vary, and it may take several days to notice the full benefits.

Xatral SR should be taken exactly as prescribed, preferably after a meal to enhance absorption. It is important to swallow the tablet whole and not crush or chew it. Patients should avoid sudden changes in posture, such as standing up quickly, as this may cause dizziness. Regular follow-ups with a healthcare provider are recommended.

Alcohol and certain medications, including other alpha-blockers and blood pressure drugs, may interact with Xatral SR, potentially increasing the risk of side effects like dizziness or low blood pressure. It is advisable to inform your healthcare provider about all medications and supplements you are taking before starting this treatment.